selvakumar subbian
Public Health Research Institute, New Jersey Medical School, Rutgers, The State University of New Jersey
Newark, United States
Review Editor
Inflammation Pharmacology
Public Health Research Institute, New Jersey Medical School, Rutgers, The State University of New Jersey
Newark, United States
Review Editor
Inflammation Pharmacology
University of Michigan
Ann Arbor, United States
Review Editor
Inflammation Pharmacology
Harvard University
Cambridge, United States
Review Editor
Inflammation Pharmacology
Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg
Gothenburg, Sweden
Review Editor
Inflammation Pharmacology
University of PĂ©cs
PĂ©cs, Hungary
Review Editor
Inflammation Pharmacology
Aarhus University
Aarhus, Denmark
Review Editor
Inflammation Pharmacology
University of Verona
Verona, Italy
Review Editor
Inflammation Pharmacology
Kyoto Pharmaceutical University
Kyoto, Japan
Review Editor
Inflammation Pharmacology
Nanyang Technological University
Singapore, Singapore
Review Editor
Inflammation Pharmacology
Nanyang Technological University
Singapore, Singapore
Review Editor
Inflammation Pharmacology
National Health Research Institutes (Taiwan)
Hsinchu, Taiwan
Review Editor
Inflammation Pharmacology
China Medical University (Taiwan)
Taichung, Taiwan
Review Editor
Inflammation Pharmacology
University of Pennsylvania
Philadelphia, United States
Review Editor
Inflammation Pharmacology
University of Naples Federico II
Naples, Italy
Review Editor
Inflammation Pharmacology
Department of Diagnostics and Public Health, University of Verona
Verona, Italy
Review Editor
Inflammation Pharmacology
Harvard Medical School
Boston, United States
Review Editor
Inflammation Pharmacology